TheFly.com
INCY
Incyte
$
()
Incyte gets payment from CMS Skinhealth for povorcitinib commercialization
Incyte, CMS enter collaboration, license agreement for povorcitinib in China
Incyte participates in a conference call with JPMorgan
Incyte participates in a conference call with JPMorgan
Incyte price target lowered by $2 at BofA, here's why
Incyte to hold a conference call
Incyte to hold a conference call
Incyte announces new data from Phase 2 study evaluating ruxolitinib cream
Incyte presents late-breaking data from Phase 2 trial evaluating povorcitinib
Incyte to hold a conference call
Incyte initiated with bullish view at Jefferies, here's why
Incyte price target raised by $6 at BMO Capital, here's why
Incyte price target raised by $2 at RBC Capital, here's why
Copyright ©1998-2024 Thefly.com LLC
